Yanlin Jian

机构：First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0001-8101-6159

发表论文 42 篇 · 总被引 809 次 · h-index 15

代表论文

• Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1 (2025 · Cell Metabolism · 被引 52)
• MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation (2024 · Nature Communications · 被引 43)
• A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy (2024 · Journal of Medicinal Chemistry · 被引 42)
• Development of a Double-Stapled Peptide Stabilizing Both α-Helix and β-Sheet Structures for Degrading Transcription Factor AR-V7 (2024 · JACS Au · 被引 35)
• Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapy (2024 · EBioMedicine · 被引 33)
• TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks (2023 · Nature Communications · 被引 26)